Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review

Multidrug-resistant tuberculosis (MDR-TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> which is resistant to at least isoniazid and rifampicin. This disease is a worldwide threat and complicates the control of tuberculosis (TB). Long treatment duration, a combinat...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Scientia Pharmaceutica
المؤلفون الرئيسيون:	Rhea Veda Nugraha, Vycke Yunivita, Prayudi Santoso, Rob E. Aarnoutse, Rovina Ruslami
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2021-05-01
الموضوعات:	clofazimine MDR-TB efficacy safety tolerability
الوصول للمادة أونلاين:	https://www.mdpi.com/2218-0532/89/2/19

مواد مشابهة

Clofazimine for the treatment of tuberculosis
حسب: Jacob A. M. Stadler, وآخرون
منشور في: (2023-02-01)

Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review
حسب: Rhea Veda Nugraha, وآخرون
منشور في: (2023-08-01)

Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
حسب: A. I. Gayda, وآخرون
منشور في: (2024-05-01)

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems
حسب: Daniélle van Staden, وآخرون
منشور في: (2022-06-01)

Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in Mycobacterium tuberculosis
حسب: Jin Shi, وآخرون
منشور في: (2023-10-01)

Effective Visual Media to Increase Knowledge and Comprehension of Multidrug Resistant Tuberculosis Among Patients and Their Caregivers
حسب: Lidya Chaidir, وآخرون
منشور في: (2023-06-01)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
حسب: Lei Zhang, وآخرون
منشور في: (2023-10-01)

Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients
حسب: Yuanyuan Shang, وآخرون
منشور في: (2023-06-01)

Factors associated with multidrug-resistant tuberculosis
حسب: Md Nurul Amin, وآخرون
منشور في: (2009-01-01)

Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
حسب: Datta Maroti Pawde, وآخرون
منشور في: (2020-12-01)

Mycobactin and clofazimine activity are negatively correlated in mycobacteria
حسب: Martin I. Voskuil, وآخرون
منشور في: (2025-04-01)

Drug susceptibilities of Mycobacterium tuberculosis against injectable second-line drugs from Pakistan: Analysis of multidrug-resistant and non-multidrug-resistant tuberculosis strains
حسب: Kauser Jabeen, وآخرون
منشور في: (2015-01-01)

Is Itraconazole Plus Clofazimine an Effective Treatment for Cutaneous Leishmaniasis?
حسب: Maryam sadat Sadati, وآخرون
منشور في: (2024-09-01)

Risk Factors for Multidrug-resistant Tuberculosis
حسب: Cleopas Martin Rumende
منشور في: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
حسب: Cleopas Martin Rumende
منشور في: (2018-04-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
حسب: E. Pontali, وآخرون
منشور في: (2024-11-01)

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
حسب: C. Zeng, وآخرون
منشور في: (2025-05-01)

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
حسب: Isabelle Bonnet, وآخرون
منشور في: (2022-06-01)

Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge
حسب: Shahram Kahkouee, وآخرون

Low-level BTZ-043 resistance in Mycobacterium tuberculosis and cross-resistance to bedaquiline and clofazimine
حسب: A. Ghodousi, وآخرون
منشور في: (2025-10-01)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
حسب: Giuseppe Mancuso, وآخرون
منشور في: (2023-09-01)

Clofazimine: History and Perspectives
حسب: G. N. Mozhokina, وآخرون
منشور في: (2021-06-01)

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
حسب: Taher Azimi, وآخرون
منشور في: (2022-08-01)

Clofazimine: A Promising Inhibitor of Rabies Virus
حسب: Jiajing Wu, وآخرون
منشور في: (2021-03-01)

Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment
حسب: Druva Sarika Rongala, وآخرون
منشور في: (2024-06-01)

Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis?
حسب: Dharmendra Singh, وآخرون
منشور في: (2024-09-01)

Evaluation of the multiple doses thiozonide’s pharmacokinetics in patients diagnosed with pulmonary tuberculosis with multidrug-resistant or extensively drug-resistant <i>Mycobacterium tuberculosis</i>
حسب: А. Yu. Savchenko, وآخرون
منشور في: (2024-01-01)

The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis
حسب: Azhar Iqbal, وآخرون
منشور في: (2022-04-01)

Use of the GenoType MTBDRplus for early diagnosis of multidrug-resistant tuberculosis
حسب: O. M. Raznatovska, وآخرون
منشور في: (2017-04-01)

Characterization of Mycobacterium tuberculosis genotypes and their correlation to multidrug resistance in Lusaka, Zambia
حسب: Eddie Samuneti Solo, وآخرون
منشور في: (2021-01-01)

Workshop Online: Prosedur Analisis Multidrug-Resistance Tuberculosis (MDR-TB) dengan Teknik Sekuensing Bagi Guru SD, SMP dan SMA
حسب: Maharani Pertiwi Koentjoro, وآخرون
منشور في: (2021-05-01)

A CASE OF AN HIV- POSITIVE PATIENT CO-INFECTED WITH MULTIDRUG-RESISTANT TUBERCULOSIS
حسب: Nina Yancheva-Petrova, وآخرون
منشور في: (2019-06-01)

Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia
حسب: Girma Mulisa, وآخرون
منشور في: (2015-10-01)

Analysis of Adverse Drug Reactions of Clofazimine Reported in the FDA Adverse Event Reporting System from 2004 to 2025 Q1
حسب: Ruoyu Zhang, وآخرون
منشور في: (2025-09-01)

The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China
حسب: Ke H, وآخرون
منشور في: (2023-08-01)

Disseminated Mycobacterium chimaera infection successfully treated with a clofazimine-containing regimen and long-term follow-up after discontinuing treatment
حسب: Takaaki Kobayashi, وآخرون
منشور في: (2024-01-01)

Individualised treatment for multidrug‐resistant tuberculosis in New South Wales, Australia
حسب: Vicky Chang, وآخرون
منشور في: (2021-10-01)

Design of Clofazimine-Loaded Lipid Nanoparticles Using Smart Pharmaceutical Technology Approaches
حسب: Helena Rouco, وآخرون
منشور في: (2025-07-01)

Exploring health care providers’ engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study
حسب: Bereket Aberham Lajore, وآخرون
منشور في: (2024-04-01)

Identification of Serum Cytokine Biomarkers Associated with Multidrug Resistant Tuberculosis (MDR-TB)
حسب: Gloria Ivy Mensah, وآخرون
منشور في: (2021-10-01)